CONSOLIDATION OF FIRST REMISSION WITH 90Y-IBRITUMOMAB TIUXETAN IN ADVANCED FOLLICULAR NON-HODGKIN'S LYMPHOMA (FL): RESULTS FROM THE PHASE 3 RANDOMIZED FIRST-LINE INDOLENT TRIAL (FIT)

U. Vitolo; F. Morschhauser; J. A. Radford; A. Van Hoof; P. Soubeyran; H. Tilly; P. C. Huijgens; A. Kolstad; M. Kunz; A. Hagenbeek

CONSOLIDATION OF FIRST REMISSION WITH 90Y-IBRITUMOMAB TIUXETAN IN ADVANCED FOLLICULAR NON-HODGKIN'S LYMPHOMA (FL): RESULTS FROM THE PHASE 3 RANDOMIZED FIRST-LINE INDOLENT TRIAL (FIT)

U. Vitolo, F. Morschhauser, J. A. Radford, A. Van Hoof, P. Soubeyran, H. Tilly, P. C. Huijgens, A. Kolstad, M. Kunz, A. Hagenbeek

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	Undefined
Pages (from-to)	231-232
Number of pages	2
Journal	Annals of Oncology
Volume	19
Publication status	Published - Sept 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{361629cdf55043e6a4580f1220089228,

title = "CONSOLIDATION OF FIRST REMISSION WITH 90Y-IBRITUMOMAB TIUXETAN IN ADVANCED FOLLICULAR NON-HODGKIN'S LYMPHOMA (FL): RESULTS FROM THE PHASE 3 RANDOMIZED FIRST-LINE INDOLENT TRIAL (FIT)",

author = "U. Vitolo and F. Morschhauser and Radford, {J. A.} and {Van Hoof}, A. and P. Soubeyran and H. Tilly and Huijgens, {P. C.} and A. Kolstad and M. Kunz and A. Hagenbeek",

year = "2008",

month = sep,

language = "Undefined",

volume = "19",

pages = "231--232",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - CONSOLIDATION OF FIRST REMISSION WITH 90Y-IBRITUMOMAB TIUXETAN IN ADVANCED FOLLICULAR NON-HODGKIN'S LYMPHOMA (FL)

T2 - RESULTS FROM THE PHASE 3 RANDOMIZED FIRST-LINE INDOLENT TRIAL (FIT)

AU - Vitolo, U.

AU - Morschhauser, F.

AU - Radford, J. A.

AU - Van Hoof, A.

AU - Soubeyran, P.

AU - Tilly, H.

AU - Huijgens, P. C.

AU - Kolstad, A.

AU - Kunz, M.

AU - Hagenbeek, A.

PY - 2008/9

Y1 - 2008/9

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000259973300736&KeyUID=WOS:000259973300736

M3 - Meeting Abstract

SN - 0923-7534

VL - 19

SP - 231

EP - 232

JO - Annals of Oncology

JF - Annals of Oncology

ER -

CONSOLIDATION OF FIRST REMISSION WITH 90Y-IBRITUMOMAB TIUXETAN IN ADVANCED FOLLICULAR NON-HODGKIN'S LYMPHOMA (FL): RESULTS FROM THE PHASE 3 RANDOMIZED FIRST-LINE INDOLENT TRIAL (FIT)

UN SDGs

Other files and links

Cite this